A Randomized phase III trial comparing conventional-dose chemotherapy using paclitaxel, ifosfamide, and cisplatin (TIP) with high dose chemotherapy using mobilizing paclitaxel followed by High-dose carboplatin and etoposide (TI-CE) as first salvage treatment in relapsed or refractory germ cell tumours

Cisplatin, Ifosfamid, Paclitaxel, Carboplatin, Etoposid

Status: Rekrutierung beendet

Klinische Settings

Beteiligte

Identifier

Links

Kontakt